Local Regulatory Partner for EU & US
Facilitating Safe and Effective Pharmaceuticals through Local Regulatory Collaboration
In the pharmaceutical sector,local health authorities generally collaborate with pharmaceutical companies to supervise and approve medications and medical equipment for efficacy and safety. This process involves examining clinical trial data, monitoring post-approval safety, and inspecting manufacturing facilities. Several important health agencies include the European Medicines Agency (EMA), the Japanese Pharmaceuticals and Medical Devices Agency (PMDA), and the US Food and Drug Administration (FDA). These organisations are essential in maintaining public health because they establish guidelines and implement rules pertaining to the creation and dispensing of pharmaceuticals.
It takes in-depth knowledge and experience to navigate the intricate regulatory environments of the US and the EU. Our team has extensive experience working with various health agencies like the FDA, EMA, and Health Canada. We understand the importance of building strong relationships with these authorities and can help navigate the complex regulatory environment to achieve your goals.
Here at Zenovel, we provide committed regulatory collaboration services to support the approval and success of your pharmaceutical products in these vital regions.
Experienced professionals with vast knowledge of FDA and EU regulations
Streamline process, Reduce time to market, Minimize delays
Mitigate risk, Enhance approval success rates
Acts as a local partner, Offer insights
The European Union’s Good Manufacturing Practice (GMP) standards, as outlined in the Annex to the Guide to Good Manufacturing Practice for Medicinal Products, ensure the quality and safety of medicinal products, including those used in clinical trials. The Qualified Person (QP) plays a crucial role in batch certification, particularly for
In the intricate process of developing new pharmaceuticals, guaranteeing product safety, effectiveness, and adherence to global regulations is essential. Batch release testing acts as a pivotal quality assurance measure, confirming that medications comply with rigorous criteria before distribution. When combined with International Council for Harmonisation (ICH) standards, this testing framework
In the world of life sciences, quality isn’t just a benchmark—it’s the backbone of success. Three key pillars—Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP)—form the core framework that supports everything from product development to regulatory approval. These standards aren’t just industry buzzwords; they’re the
In the pharmaceutical industry, quality is paramount—and at Zenovel, we are deeply committed to delivering excellence in Quality Assurance (QA). Our focus is on ensuring that every medicine is developed, manufactured, and delivered with safety and reliability as top priorities. QA is embedded in every stage of the pharmaceutical lifecycle—from
The U.S. Food and Drug Administration (FDA) emphasize the importance of data integrity in pharmaceutical manufacturing, particularly under its Current Good Manufacturing Practices (CGMP) rules. However, issues like fake lab results and sloppy record-keeping persist, posing risks to patients and losing confidence in the system. Independent oversight is crucial to
In the rapidly evolving pharmaceutical industry, assuring product quality and customer safety is a need. This endeavour continues to be based on validation, a methodical procedure to verify that manufacturing procedures and equipment consistently deliver high-quality outcomes. A strong strategy to validation is required in 2025 due to the complexity
